Press release
Nicotinamide Mononucleotide (NMN) Market Size is projected to reach USD 428.14 million, growing at a CAGR of 8.2% | GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical
Exactitude Consultancy Market Research analyses that the Nicotinamide Mononucleotide (NMN) Market will witness a CAGR of 8.2% for the forecast period of 2023-2029 and is likely USD 210.64 million in 2022 to reach at USD 428.14 million by 2029.Research report on the Nicotinamide Mononucleotide (NMN) market allows buyers to deliver unique solutions to various end users and improve their business presence in the industry. The report is introduced with accurate statistics regarding market share, size, and growth rate for the buyers to focus on their operations and achieve various goals smoothly. Numerous driving factors, restraints, opportunities, and threats affecting the Nicotinamide Mononucleotide (NMN) market growth is described in the study for the strategy planners to plan policies pertaining to production volume, delivery of services, making connections, and creating awareness in the minds of consumers.
Request a Sample PDF Including Full TOC, a List of Tables & Figures, and a Chart:
https://exactitudeconsultancy.com/reports/3368/nicotinamide-mononucleotide-nmn-market/#request-a-sample
Nicotinamide Mononucleotide (NMN) Market Strategic Analysis
To assess the market, the research study employs a number of analytical approaches, including Porter's Five Forces, SWOT analysis, player positioning analysis, market share analysis, and value chain analysis. This nicotinamide mononucleotide (nmn) evaluation assists users in analyzing the market using a variety of metrics, including switching costs, economies of scale, current sales network, brand loyalty, capital investment, product rights and patents, regulatory legislation, promotional effects, and customers. It is intended that the information presented here will assist industry stakeholders in making decisions.
Prominent Key players of the Nicotinamide Mononucleotide (NMN) Market survey report:
Historical data available in the report elaborates on the development of the Nicotinamide Mononucleotide (NMN) on national, regional and international levels. Market Research Report presents a detailed analysis based on the thorough research of the overall market, particularly on questions that border on the market size, growth scenario, potential opportunities, operation landscape, trend analysis, and competitive analysis. Some Key Competitors of the Market are - GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, Bontac, Shandong Sihuan Pharmaceutical, EffePharm, Zhejiang Jiahua Pharmchemicals.
Industry News
✦ August 7, 2020 - NMN Established as Safe in First Human Trials
GeneHarbor study for the results of the first human study of Nicotinamide Mononucleotide (NMN) were published. The study was conducted at the Clinical Trial Unit, Keio University School of Medicine, Japan and included a total sample of 10 healthy Japanese men between the ages of 40 and 60 years old. Subjects received a single dose of 100, 250, or 500 mg NMN capsules.
✦ 30, 2019 - Herbalmax announces Reinvigorator Basic, as part of their expanded product-range of Nicotinamide Mononucleotide (NMN) -based nutraceuticals, enhanced with herbal compounds for metabolic optimization and healthy aging.
Nicotinamide Mononucleotide (NMN) Market Segmentation:
NMN Market By Type, 2023-2029, ( USD Million) (Kilotons)
» Content Below 98%
» Content Above 98%
NMN Market By Application, 2023-2029, (USD Million) (Kilotons)
» Health Care Products
» Cosmetics
The regional outlook by revenue covers the countries namely:
✦ North America (United States, Canada and Mexico)
✦ Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
✦ Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
✦ South America (Brazil, Argentina, Colombia, and Rest of South America)
✦ Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Read Full Report with TOC:
https://exactitudeconsultancy.com/reports/3368/nicotinamide-mononucleotide-nmn-market/?mode=P166
Key Features of the Nicotinamide Mononucleotide (NMN) Market Report: -
⇨ Analyse competitive developments such as expansions, deployments, new product launches, and market acquisitions.
⇨ Examine the market opportunities for stakeholders by identifying higher growth sections.
⇨ To study and analyse the global Nicotinamide Mononucleotide (NMN) industry status and forecast including key regions.
⇨ An in-depth analysis of key product segments and application spectrum, providing strategic recommendations to incumbents and new entrants to give them a competitive advantage over others.
⇨ It provides a comprehensive analysis of key regions of the industry as well as a SWOT analysis and Porter's Five Forces analysis to provide a deeper understanding of the market.
⇨ It helps you make strategic business decisions and investment plans.
Competitive Landscape
Competition has been growing for the Nicotinamide Mononucleotide (NMN) industry as the supply and demand has been on an increasing trend sine past decade. This report gives a detailed analysis of the presence of various small, medium and micro enterprises in the industry of numerous scales, their relative sizes, product offerings, and market positions in the pre and post pandemic situations. Additionally, the report provides an overview of the competitor strategy with regards to business and corporate office and functions have been provided. The report also mentions about the operations, technology infrastructure, marketing strategies and financial capabilities. Thus, the report gives a very good understanding of the market to the shareholders and stakeholders from an overall perspective.
Highlight the Following Key Factors:
► Business Description: a particular description of agency operations and enterprise departments.
► Company Strategy: The analyst's precis of the company's commercial enterprise strategy.
► SWOT Analysis: Detailed evaluation of the company's strengths, weaknesses, opportunities, and threats.
► Company History: The development of predominant occasions associated to the company.
► Main merchandise and services: A listing of the company's fundamental products, services, and brands.
► Main Competitors: A listing of the company's fundamental competitors.
► Important places and subsidiaries: The company's major places and subsidiaries' listing and contact information.
► Detailed economic ratios of the previous 5 years: The trendy monetary ratios come from the annual economic statements issued by means of agencies with a record of 5 years.
Table of Contents
Global Nicotinamide Mononucleotide (NMN) Market Research Report 2023-2029
1 Nicotinamide Mononucleotide (NMN) Market Overview
1.1 Product Overview and Scope of Nicotinamide Mononucleotide (NMN)
1.2 Nicotinamide Mononucleotide (NMN) Segment by Type (Product Category)
1.3 Global Nicotinamide Mononucleotide (NMN) market Segment by Application
1.4 Global Nicotinamide Mononucleotide (NMN) Market by Region (2023-2029)
1.4.1 Global Nicotinamide Mononucleotide (NMN) Market Size (Value) and CAGR (%) Comparison by Region (2023-2029)
1.4.2 North America Status and Prospect (2023-2029
1.4.3 Europe Status and Prospect (2023-2029)
1.4.4 China Status and Prospect (2023-2029)
1.4.5 Japan Status and Prospect (2023-2029)
1.4.6 Southeast Asia Status and Prospect (2023-2029)
1.4.7 India Status and Prospect (2023-2029)
1.5 Global Market Size (Value) of Nicotinamide Mononucleotide (NMN) (2023-2029)
1.5.1 Global Nicotinamide Mononucleotide (NMN) Revenue Status and Outlook (2023-2029)
1.5.2 Global Nicotinamide Mononucleotide (NMN) Capacity, Production Status and Outlook (2023-2029)
…
Why Choose Nicotinamide Mononucleotide (NMN) Market Report?
✔ Unbiased conclusions and market insights
✔ 24×7 customer service available to address client queries
✔ Highly efficient and experienced team of analysts striving to create top-quality reports
✔ Our reports have facilitated the growth of over 500 companies
✔ The systematic and methodical market research process
Thank you for your interest in the Nicotinamide Mononucleotide (NMN) Market research publications; you can also get individual chapters or regional/country report versions such as Germany, France, China, Latin America, GCC, North America, Europe or Asia.
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
Contact us
for your special interest research needs at sales@exactitudeconsultancy.com and we will get in touch with you within 24hrs and help you find the market research report you need.
Contact: Irfan Tamboli
Phone Number: +91-7507-07-8687
Website: https://exactitudeconsultancy.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nicotinamide Mononucleotide (NMN) Market Size is projected to reach USD 428.14 million, growing at a CAGR of 8.2% | GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical here
News-ID: 3246470 • Views: …
More Releases from Exactitude Consultancy

Relapsed/Refractory Acute Myeloid Leukemia Market is expected to reach USD 6.1 b …
Acute myeloid leukemia (AML) is a highly aggressive hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and blood. Despite advances in frontline therapies, relapse is common, and many patients develop refractory disease, leaving limited treatment options and poor survival outcomes. Relapsed/refractory AML (R/R AML) remains a major unmet clinical need.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71571
In recent years, however, the…

Retinoblastoma Market to Reach USD 1.2 Billion by 2034
Retinoblastoma is a rare pediatric eye cancer that originates in the retina and primarily affects children under five years of age. It accounts for around 3% of all childhood cancers but is the most common intraocular malignancy in children. With improved awareness, early screening, and advances in treatment, survival rates in developed nations exceed 90%. However, challenges remain in low- and middle-income countries where delayed diagnosis and limited access to…

Severe Toxicities in Lymphoma Market Projected to Reach USD 3.7 Billion by 2034
Lymphoma, a group of blood cancers affecting the lymphatic system, is broadly classified into Hodgkin's lymphoma (HL) and non-Hodgkin's lymphoma (NHL). While survival outcomes have improved significantly with chemotherapy, radiotherapy, targeted agents, and immunotherapies, many patients experience severe toxicities as side effects of treatment. These toxicities - ranging from cytokine release syndrome (CRS) and neurotoxicity in CAR-T therapy to myelosuppression, infections, and organ toxicities from chemotherapy and immunomodulators - can…

Soft Tissue Neoplasms Market to Reach USD 6.0 Billion by 2034
Soft tissue neoplasms are abnormal growths arising from connective tissues, including muscles, fat, nerves, tendons, and blood vessels. While some are benign, malignant forms such as soft tissue sarcomas (STS) pose serious clinical challenges due to their aggressive nature, rarity, and diverse histological subtypes. Representing about 1% of all adult cancers, these neoplasms require a wide spectrum of treatments ranging from surgery and radiotherapy to chemotherapy and novel targeted therapies.
Download…
More Releases for NMN
Liposomal NMN vs. Standard NMN: What One Needs to Know
Introduction: Why Your NMN Needs Protection
Still taking "naked" NMN? Without protection, much of it is lost in digestion before it can make a difference. Liposomal NMN uses cutting-edge encapsulation to bypass the digestive system, protect the active ingredient, and deliver it straight to target cells - for stability, efficiency, and results.
Image: https://ecdn6.globalso.com/upload/p/2011/image_other/2025-08/640.png
Why Regular NMN Falls Short
NMN is absorbed through a special intestinal transporter (SLC12A8) to raise NAD levels in the…
NMN Powder Market Research Report 2025
Global Info Research announces the release of the report "Global NMN Powder Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides a detailed overview of the NMN Powder market scenario, including a thorough analysis of the NMN Powder market size, sales quantity, average price, revenue, gross margin and market share.The NMN Powder report provides an in-depth analysis of the competitive landscape, manufacturer's profiles, regional and…
Nicotinamide Mononucleotide (NMN) Market Growth, Trends, and Opportunities From …
A newly published report by Exactitude Consultancy on the "Nicotinamide Mononucleotide (NMN) Market 2025" offers a detailed overview of the industry, featuring insights into competitive landscapes and market segments. The report incorporates graphs, tables, and charts to present data in a user-friendly format, making it easy to analyze and compare figures. Serving as a central source of market information, the research highlights key challenges and future growth opportunities. Additionally, the…
NAD-based Anti-Aging Market Top Players - GenF20 Liposomal NMN, Wonderfeel, part …
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global NAD-based Anti-Aging Market Size, Share & Trends Analysis Report By Type (Supplements (Oral NAD Dietary Supplements, Topical NAD Supplements (Creams, Serums, Lip Creams, Eye Creams)) Therapeutic Products (NAD Nasal Spray, and NAD injections/NAD IV)), Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Convenience Stores, Pharmacies/Clinics, Online Stores)…
Liposomal NMN: The Ultimate Solution for Anti-Aging
Liposomal NMN by Genuine Purity stands out in the crowded field of anti-aging product with its advanced formulation designed to boost NAD+ levels effectively. NMN, or Nicotinamide Mononucleotide, is a precursor to NAD+ (Nicotinamide Adenine Dinucleotide), a critical coenzyme involved in numerous cellular processes, including energy metabolism and DNA repair. Genuine Purity's liposomal delivery system ensures that NMN is absorbed efficiently, maximizing its benefits. [https://bit.ly/3VvcRMx]
The liposomal encapsulation technology used in…
llabs. Now Offers Revolutionary Healthy Aging Product: NMN
llabs., a leader in health supplements focused on promoting healthy aging, proudly announces the launch of its flagship product, NMN, alongside its complementary products, TMG Betaine and Fisetin. These innovative products are set to provide valuable support for those looking to maintain their vitality and well-being as they age.
llabs., known for its commitment to quality and global reach, introduces NMN as the hero product, designed to support healthy aging and…